Reitz RH - Search Results

1

In vitro metabolism of methylene chloride in human and animal tissues: use in physiologically based pharmacokinetic models.

Reitz RH, Mendrala AL, Guengerich FP. Reitz RH, et al. Toxicol Appl Pharmacol. 1989 Feb;97(2):230-46. doi: 10.1016/0041-008x(89)90328-1. Toxicol Appl Pharmacol. 1989. PMID: 2922756

2

Estimating the risk of liver cancer associated with human exposures to chloroform using physiologically based pharmacokinetic modeling.

Reitz RH, Mendrala AL, Corley RA, Quast JF, Gargas ML, Andersen ME, Staats DA, Conolly RB. Reitz RH, et al. Toxicol Appl Pharmacol. 1990 Sep 15;105(3):443-59. doi: 10.1016/0041-008x(90)90148-n. Toxicol Appl Pharmacol. 1990. PMID: 2237918

3

Development of a physiologically based pharmacokinetic model for chloroform.

Corley RA, Mendrala AL, Smith FA, Staats DA, Gargas ML, Conolly RB, Andersen ME, Reitz RH. Corley RA, et al. Among authors: reitz rh. Toxicol Appl Pharmacol. 1990 May;103(3):512-27. doi: 10.1016/0041-008x(90)90324-n. Toxicol Appl Pharmacol. 1990. PMID: 2339423

4

Incorporation of in vitro enzyme data into the physiologically-based pharmacokinetic (PB-PK) model for methylene chloride: implications for risk assessment.

Reitz RH, Mendrala AL, Park CN, Andersen ME, Guengerich FP. Reitz RH, et al. Toxicol Lett. 1988 Oct;43(1-3):97-116. doi: 10.1016/0378-4274(88)90023-9. Toxicol Lett. 1988. PMID: 3176073

5

In vivo and in vitro studies of perchloroethylene metabolism for physiologically based pharmacokinetic modeling in rats, mice, and humans.

Reitz RH, Gargas ML, Mendrala AL, Schumann AM. Reitz RH, et al. Toxicol Appl Pharmacol. 1996 Feb;136(2):289-306. doi: 10.1006/taap.1996.0036. Toxicol Appl Pharmacol. 1996. PMID: 8619237

6

Comment on M.V. Evans and J.C. Caldwell: evaluation of two different metabolic hypotheses for dichloromethane toxicity using physiologically based pharmacokinetic modeling of in vivo gas uptake data exposure in female B6C3F1 mice, Toxicol. Appl. Pharmacol., 244, 280-290, 2010.

Anders MW, Andersen ME, Clewell HJ 3rd, Gargas ML, Guengerich FP, Reitz RH. Anders MW, et al. Among authors: reitz rh. Toxicol Appl Pharmacol. 2010 Oct 1;248(1):63-4; author reply 65-7. doi: 10.1016/j.taap.2010.07.012. Epub 2010 Jul 22. Toxicol Appl Pharmacol. 2010. PMID: 20655322 No abstract available.

7

Physiologically based pharmacokinetic modeling with methylchloroform: implications for interspecies, high dose/low dose, and dose route extrapolations.

Reitz RH, McDougal JN, Himmelstein MW, Nolan RJ, Schumann AM. Reitz RH, et al. Toxicol Appl Pharmacol. 1988 Sep 15;95(2):185-99. doi: 10.1016/0041-008x(88)90155-x. Toxicol Appl Pharmacol. 1988. PMID: 3420611

8

Development of a physiologically based pharmacokinetic model for risk assessment with 1,4-dioxane.

Reitz RH, McCroskey PS, Park CN, Andersen ME, Gargas ML. Reitz RH, et al. Toxicol Appl Pharmacol. 1990 Aug;105(1):37-54. doi: 10.1016/0041-008x(90)90357-z. Toxicol Appl Pharmacol. 1990. PMID: 2392805

9

Predicting cancer risk from vinyl chloride exposure with a physiologically based pharmacokinetic model.

Reitz RH, Gargas ML, Andersen ME, Provan WM, Green TL. Reitz RH, et al. Toxicol Appl Pharmacol. 1996 Apr;137(2):253-67. doi: 10.1006/taap.1996.0079. Toxicol Appl Pharmacol. 1996. PMID: 8661351

10

Physiologically based pharmacokinetics and the risk assessment process for methylene chloride.

Andersen ME, Clewell HJ 3rd, Gargas ML, Smith FA, Reitz RH. Andersen ME, et al. Among authors: reitz rh. Toxicol Appl Pharmacol. 1987 Feb;87(2):185-205. doi: 10.1016/0041-008x(87)90281-x. Toxicol Appl Pharmacol. 1987. PMID: 3824380

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

42 results

Search Page